Log in
Register
Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
More options
Toggle width
Share this page
Share this page
Share
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Menu
Install the app
Install
Forums
Law Firm Events
Law Firm Deadlines
TCLA TV
Members
Leaderboards
Premium Database
Premium Chat
Commercial Awareness
Future Trainee Advice
Forums
Aspiring Lawyers - Interviews & Vacation Schemes
Commercial Awareness Discussion
confused to commercially aware! trying to develop my commercial awareness
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="confusedlawstudent" data-source="post: 129664" data-attributes="member: 17277"><p>In my preparation for my CMS VI, I was looking at a recent deal they worked on, so I thought I would write a quick post on it!</p><p></p><p><strong>Sale of InstaDeep to BioNTech</strong></p><p></p><p>InstaDeep delivers AI-powered decision making stystems. BioNTech is a biotech company developing immunotherapies for cancer and other diseases. This is reflective of a very common trend in recent years of pharma companies investing in AI to improve efficiency and accelerate the costly process of drug discovery (for example, we saw back in 2021 Bristol-Myers Squibb entered a drug discovery collaboration with AI start-up Excientia).</p><p></p><p>Why did BioNTech do this deal? It is a shortcut to AI technology. It saves them from the cost of developing their own AI. The deal also gives them access to the talent needed to use this AI and also to improve it. </p><p></p><p>Role of CMS in the deal:</p><p>- Corporate lawyers will advise on the due diligence, and determining what exactly is being acquired.</p><p>- Commercial lawyers will draft the agreements - the initial NDA and the final share purchase agreement.</p><p>- IP lawyers will advise on the transfer of the patent rights to the AI technology, and making sure it is registered in the relevant registers to ensure BioNTech can enforce the rights.</p><p>- Employment lawyers will advise on the transfer of any employees as a result of the acquisition. </p><p></p><p>How this will affect other CMS clients:</p><p>AI improves efficiency in drug discovery, so the deal will increase competition in the market. More and more pharma companies are going to want to use AI to improve efficiency and innovation in order to stay on top. And generally, the use of AI will change the way pharma companies practise - they will have a more data driven approach to drug discovery, and even health care companies will have a data driven approach to patient categorisation.</p></blockquote><p></p>
[QUOTE="confusedlawstudent, post: 129664, member: 17277"] In my preparation for my CMS VI, I was looking at a recent deal they worked on, so I thought I would write a quick post on it! [B]Sale of InstaDeep to BioNTech[/B] InstaDeep delivers AI-powered decision making stystems. BioNTech is a biotech company developing immunotherapies for cancer and other diseases. This is reflective of a very common trend in recent years of pharma companies investing in AI to improve efficiency and accelerate the costly process of drug discovery (for example, we saw back in 2021 Bristol-Myers Squibb entered a drug discovery collaboration with AI start-up Excientia). Why did BioNTech do this deal? It is a shortcut to AI technology. It saves them from the cost of developing their own AI. The deal also gives them access to the talent needed to use this AI and also to improve it. Role of CMS in the deal: - Corporate lawyers will advise on the due diligence, and determining what exactly is being acquired. - Commercial lawyers will draft the agreements - the initial NDA and the final share purchase agreement. - IP lawyers will advise on the transfer of the patent rights to the AI technology, and making sure it is registered in the relevant registers to ensure BioNTech can enforce the rights. - Employment lawyers will advise on the transfer of any employees as a result of the acquisition. How this will affect other CMS clients: AI improves efficiency in drug discovery, so the deal will increase competition in the market. More and more pharma companies are going to want to use AI to improve efficiency and innovation in order to stay on top. And generally, the use of AI will change the way pharma companies practise - they will have a more data driven approach to drug discovery, and even health care companies will have a data driven approach to patient categorisation. [/QUOTE]
Insert quotes…
Verification
Our company is called, "The Corporate ___ Academy". What is the missing word here?
Post reply
Forums
Aspiring Lawyers - Interviews & Vacation Schemes
Commercial Awareness Discussion
confused to commercially aware! trying to develop my commercial awareness
Top
Bottom
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…